6080_SIU2016_SIU@U_Broadcast_schedule_spr
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
BROADCAST<br />
SCHEDULE<br />
2016<br />
www.siu-urology.org<br />
#siu16
20<br />
THURSDAY<br />
OCTOBER<br />
<strong>SIU@U</strong> Inaugural Session<br />
1400–1515<br />
The Hidden Condition(s)—How to Best Treat Patients with LUTS<br />
and Comorbidities: A Roundtable Discussion<br />
Chair: Stavros Gravas, Greece<br />
Sign up today at<br />
www.siu-urology.org/siuatu<br />
Please note that the times are listed<br />
in ART — Argentina Time (UTC -3 hours)<br />
PROGRAMME DESCRIPTION<br />
This program is a case-based discussion focusing on patients with BPH and other comorbidities<br />
(e.g., erectile dysfunction, metabolic conditions, depression, cardiovascular diseases). Discussions<br />
will include medical management/treatment, surgical and minimally invasive interventions.<br />
Panelists<br />
Dr. Joyce Baard, The Netherlands<br />
Dr. Jack Barkin, Canada<br />
Dr. Mauro Gacci, Italy<br />
Dr. Peter Gilling, New Zealand<br />
Dr. Mauricio Plata, Colombia<br />
This educational activity has been<br />
funded by SIU’s Corporate Sponsor,<br />
GlaxoSmithKline.<br />
3
0905–0955<br />
Shifting Sands—Testicular Cancer<br />
Chair: Arnulf Stenzl, Germany<br />
Radiation Exposure and Money-Sparing Follow-Up of Stage I Testicular Cancer<br />
Joel Sheinfeld, United States<br />
Revival of Surgery in Stage III Non-seminmatous Testicular Cancer<br />
Jens Bedke, Germany<br />
High-Dose Chemotherapy Necessary for Intermediate Prognosis Non-Seminomatous<br />
Testicular Cancer?<br />
Juan Pablo Sade, Argentina<br />
Indication for Organ-Sparing Surgery in Testicular Lesions<br />
Sudhir Rawal, India<br />
0955–1020<br />
Debate—Focal Therapy in Prostate Cancer: Pro vs. Con<br />
Moderator: Jean de la Rosette, The Netherlands<br />
Pro: Scott Eggener, United States<br />
Con: Markus Graefen, Germany<br />
1020–1040<br />
SIU-Astellas European Foundation Award Lecture<br />
21<br />
OCTOBER<br />
FRIDAY<br />
1040–1055<br />
Pan–African Urological Surgeons’ Association (PAUSA) Lecture<br />
The Ebola Epidemic<br />
Augustin Monga-Lembe Punga-Maole, Democratic Republic of Congo<br />
1055–1110<br />
Sociedad Argentina de Urología (SAU) Lecture<br />
Active Surveillance on Prostate Cancer<br />
Fernando Secin, Argentina<br />
1140–1310<br />
Master Class—Enhanced Recovery in Urology<br />
Chair: Sia Daneshmand, United States<br />
ERAS: Concept and Implementation Following Radical Cystectomy<br />
Sia Daneshmand, United States<br />
Strategies to Improve Recovery of Continence and Potency Following Radical Prostatectomy<br />
Markus Graefen, Germany<br />
Cytoreductive Nephrectomy: Priming Patients for Systemic Therapies<br />
Juan Ignacio Martínez-Salamanca, Spain<br />
Measuring Improvement in Quality of Life Using ERAS Protocols<br />
Alexander Karl, Germany<br />
Decreasing Readmission Rates Following Major Urologic Surgery<br />
Ashish M. Kamat, United States<br />
1310–1425<br />
Sponsored Symposium<br />
Step-by-Step Towards a Better Management of Prostate Cancer<br />
Chair: Juan Ignacio Hernández Morán, Argentina<br />
Introduction–Explaining the Steps<br />
Juan Ignacio Hernández Morán<br />
Mastering the Basics: New Guidance in the Management of mCRPC<br />
Laurence Klotz, Canada<br />
Step 2: A Successful Connection the Importance of Quality of Life in the<br />
Treatment of mCRPC Patients<br />
Javier Puente, Spain<br />
Step 3: Adding Flair to It—Gaining Insight into the Complexity of Prostate Cancer Management<br />
Christopher Evans, USA<br />
Join the Tango! Discussion and Closing Remarks<br />
Juan Ignacio Hernández Morán<br />
4<br />
5
1425–1555<br />
Overdiagnosis and Overtreatment<br />
Chair: Antonio Finelli, Canada<br />
Prostate<br />
Laurence Klotz, Canada<br />
Kidney<br />
Antonio Finelli, Canada<br />
Asymptomatic Stones<br />
Jorge Gutierrez, United States<br />
Nocturia<br />
Dean Elterman, Canada<br />
1615–1745<br />
New Therapies and Diagnoses in Bladder Cancer<br />
Chair: Ashish M. Kamat, United States<br />
Optimal Use of Novel Biomarkers and Detection Strategies for Bladder Cancer<br />
Mikio Sugimoto, Japan<br />
Emerging Strategies in Treatment of BCG Unresponsive NMIBC<br />
Per-Uno Malmström, Sweden<br />
Changing Landscape of Systemic Therapy<br />
Peter Goebell, Germany<br />
Radical Cystectomy: What Improvements Can We All Adopt?<br />
Wassim Kassouf, Canada<br />
Practical Application of New Therapies and Diagnosis in Bladder Cancer: Cases and Q&A<br />
Moderator:<br />
Stephen Williams, United States<br />
Panelists:<br />
Ashish M. Kamat, United States<br />
Mikio Sugimoto, Japan<br />
Per-Uno Malmström, Sweden<br />
Peter Goebell, Germany<br />
Wassim Kassouf, Canada<br />
1800–1830<br />
<strong>SIU@U</strong> Studio Session<br />
Debate: MRI-US Guided Biopsy vs. Transperineal<br />
Panelists: <br />
Art Rastinehad, United States<br />
Badrinath Konety, United States<br />
Rafael Sanchez-Salas, France<br />
21<br />
OCTOBER<br />
FRIDAY<br />
6
0900–0910<br />
SIU Best Video Awards Presentation<br />
Winner<br />
Transurethral Ventral Buccal Mucosa Graft Inlay Urethroplasty<br />
for Distal Urethral Strictures<br />
Dmitriy Nikolavsky, United States<br />
Runners-Up<br />
Surgical Management of Adult Acquired Buried Penis:<br />
Escutcheonectomy, Scrotectomy, and Penile Split Thickness Skin Graft<br />
Thomas Fuller, United States<br />
Mini-ECIRS in Multiple Renal Stones<br />
Marcos Cepeda, Spain<br />
0910–1015<br />
Shifting Sands—New Technologies in Stone Disease<br />
Chair: Francisco Pedro Daels, Argentina<br />
Retrograde Intrarenal Surgery: Limitations and Future<br />
Olivier Traxer, France<br />
Prevention and Treatment of Infectious Complications in Endourology<br />
Jorge Gutierrez, United States<br />
Percutaneous vs Minipercutaneous vs Ultraminipercutaneous<br />
vs Micropercutaneous Access: Which Is Best?<br />
Pradeep Rao, India<br />
Treatment of Complex Renal Stones<br />
Norberto Bernardo, Argentina<br />
Stone Disease and Pregnancy<br />
Mariano Gonzalez, Argentina<br />
Case Study and Discussion<br />
1015–1040<br />
Debate—Mesh: Pro vs. Con<br />
Moderator: Hugo Davila, Venezuela<br />
Pro: Nissrine Nakib, United States<br />
Con: Paulo Palma, Brazil<br />
22<br />
SATURDAY<br />
OCTOBER<br />
1040–1055<br />
European Association of Urology (EAU) Lecture<br />
Bladder Cancer<br />
Arnulf Stenzl, Germany<br />
1055–1110<br />
Urological Association of Asia (UAA) Lecture<br />
Holistic Approach to BPH for Individualized and Personalized Care<br />
Keong Tatt Foo, Singapore<br />
1 140–1310<br />
SIU–ICUD Joint Consultation on Urologic Management<br />
of the Spinal Cord Injured Patient<br />
Co-Chairs: Reynaldo Gomez, Chile and Sean P. Elliott, United States<br />
Epidemiology and Pathophysiology of Neurogenic Bladder After Spinal Cord Injury<br />
Rizwan Hamid, United Kingdom<br />
The Early Urologic Care of the Spinal Cord-Injured Patient<br />
Thomas Kessler, Switzerland<br />
Surveillance and Management of Urologic Complications after Spinal Cord Injury<br />
David Ginsberg, United States<br />
Non-Surgical Urologic Management of Neurogenic Bladder after Spinal Cord Injury<br />
Sergio Duran, Mexico<br />
Surgical Management of Neurogenic Bladder after Spinal Cord Injury<br />
Jean-Jacques Wyndaele, The Netherlands<br />
Sexual, Bowel and Fertility Problems in the Spinal Cord Injured Patient<br />
John Stoffel, United States<br />
Special Considerations in the Urological Management of Children with Spinal Cord Injury<br />
Marc Cendron, United States<br />
Special Considerations in the Urological Management of Geriatric Patients Spinal Cord Injury<br />
Lewis Chan, Australia<br />
Current and Future International Patterns of Care of Neurogenic Bladder after Spinal Cord Injury<br />
Roger Dmochowski, United States<br />
1330–1400<br />
<strong>SIU@U</strong> Studio Session<br />
Interview: Global Experience on Stone Management<br />
Moderator:<br />
Mahesh Desai<br />
Panelists:<br />
Francisco Daels, Argentina<br />
Jorge Gutierrez, United States<br />
Ravindra Sabnis, India<br />
Palle Osther, Denmark<br />
8<br />
9
1425–1555<br />
Stones<br />
Chair: Norberto Bernardo, Argentina<br />
Totally Tubeless PCNL—Why & How?<br />
Deok Hyun Han, South Korea<br />
Percutaneous Nephrolithotomy for Complex Pediatric Renal Calculus Disease<br />
Rajesh Kukreja, India<br />
Supracostal Access: Tubeless Percutaneous Nephrolithotomy<br />
Bannakij Lojanapiwat, Thailand<br />
Combined Retrograde Flexible Ureteroscopic Lithotripsy with Holmium Laser<br />
for Renal Stones Associated with Ipsilateral Ureteral Stones<br />
Jorge Gutierrez, United States<br />
1615–1745<br />
Global Perspectives: Urethral Reconstruction<br />
Chair: Margit Fisch, Germany<br />
Buccal Mucosa Bulbar Urethroplasty<br />
Andre Cavalcanti, Brazil<br />
Bulbar End-to-End<br />
Joel Gelman, United States<br />
Complex Penobulbar Stricture<br />
Sanjay Kulkarni, India<br />
Penile Dorsal Inlay<br />
Allen Morey, United States<br />
Post-Traumatic Stricture<br />
Daniela Andrich, United Kingdom<br />
1800–1830<br />
<strong>SIU@U</strong> Studio Session<br />
uTalks: Transgender Surgery<br />
Giulio Garaffa, United Kingdom<br />
22<br />
SATURDAY<br />
OCTOBER<br />
10<br />
11
23<br />
SUNDAY<br />
OCTOBER<br />
0900–0955<br />
Shifting Sands—Systemic Therapy vs. Immunotherapy<br />
Chair: Fred Saad, Canada<br />
Intro: Evolution of Systemic Therapies: From Cytotoxics to Targets to Immunotherapies<br />
Fred Saad, Canada<br />
Bladder Cancer: Chemotherapy or Immununotherapy? Evolution of Systemic<br />
and Intravesical Therapies<br />
Ricardo Sanchez-Ortiz, United States<br />
Kidney Cancer: Targeted Therapy or Immunotherapy in the Adjuvant and Systemic Setting<br />
Ricardo Rendon, Canada<br />
Prostate Cancer: Cytotoxics, Hormonal Targets and Immunotherapy in 2016<br />
Fred Saad, Canada<br />
0955–1020<br />
Debate—Varicocele Correction Make a Difference<br />
in the Era of Assisted Reproduction<br />
Moderator: Ranjith Ramasamy, United States<br />
1 140–1310<br />
Systemic Therapies in Prostate and Kidney Cancer: A Practical Approach<br />
Chair: Fred Saad, Canada<br />
Evolving Role of Novel Hormonal Agents in Prostate Cancer: Who, When, and How<br />
Evolving Role of Chemotherapy in Prostate Cancer: Who, When and How<br />
Evolving Role of Bone Targeted Therapy in Prostate Cancer: Who, When and How<br />
Use of Systemic Therapies in Kidney Cancer: Who, when and How<br />
Faculty:<br />
Axel Heidenreich, Germany<br />
Anil Kapoor, Canada<br />
Bertrand Tombal, France<br />
1330–1400<br />
<strong>SIU@U</strong> Studio Session<br />
U Ask-the-Experts: A Q&A Session for Residents<br />
Pilar Laguna, The Netherlands<br />
Fernando Secin, Argentina<br />
Shahrokh Shariat, Austria<br />
Arnulf Stenzl, Germany<br />
Yes: Robert Brannigan, United States<br />
No: Alex Pastuszak, United States<br />
1020–1035<br />
American Urological Association (AUA) Lecture<br />
Chronic Pelvic Pain Syndrome<br />
J. Quentin Clemens, United States<br />
1035–1050<br />
Confederación Americana de Urología (CAU) Lecture<br />
Robotic Repair of Genitourinary Fistulas<br />
René Sotelo, United States<br />
1050–1110<br />
SIU-Albert Schweitzer Award<br />
A Co-Teaching in Endo-Urology between France and Senegal: An Example<br />
of North/South Collaboration<br />
Alain Houlgatte, France<br />
12 13
1425–1555<br />
Male Incontinence<br />
Chair: Ajay Nehra, United States<br />
23<br />
OCTOBER<br />
SUNDAY<br />
Utilization of Validated Instruments and Diagnostic Modalities in the<br />
Management of Incontinence<br />
Alan Wein, United States<br />
Case Management:<br />
A) 68 year old executive, BMI 32, following an RALP for Prostate Carcinoma T3a N0 performed<br />
14 months with persistent urinary leakage (4 PPD)<br />
B) 52 year old patient with H/O bladder neck contracture and recent diagnosis of urinary incontinence<br />
following an RALP for a T2a adenocarcinoma of the Prostate<br />
C) 46 year old patient with H/O OAB, H/O bladder neck contracture following a TUR for a<br />
bladder neck contracture 3 months ago, PSA 12.8, F/H of Prostate Cancer , with recently<br />
diagnosed Prostate cancer 6/12 cores; and persistent OAB symptoms<br />
D) 60 year old patient with badder cancer following a cystoprostatectomy and a neobladder with<br />
persistent urinary incontinence<br />
E) 32 year old male with H/O neurogenic bladder, bladder capacity of 100ml and urinary incontinence<br />
Panelists:<br />
Alan Wein, United States<br />
Ja<strong>spr</strong>eet Sandhu, United States<br />
Kurt McCammon, United States<br />
Gopal Badlani, United States<br />
Rajeev Kumar, India<br />
ON<br />
DEMAND<br />
SESSIONS<br />
1615–1645<br />
<strong>SIU@U</strong> Studio Session<br />
Passing the Torch: Looking Back and Looking Ahead<br />
An interview with the outgoing and incoming SIU General Secretaries<br />
Jean de la Rosette, The Netherlands<br />
Simon Tanguay, Canada<br />
14
World Urological Oncology<br />
Federation Symposium<br />
Kidney Cancer<br />
Co-Chairs:<br />
Laurence Klotz, Canada<br />
Aaron Torres Garcia, Mexico<br />
Marcelo Bendhack, Brazil<br />
Session I: Kidney Cancer<br />
Co-Moderators:<br />
Peter Hammerer, Germany<br />
Aaron Torres Garcia, Mexico<br />
Biopsy Should Be Done Routinely<br />
for Most Small Renal Masses<br />
Antonio Finelli, Canada<br />
Biopsy Should Not Be Done Routinely for<br />
Most Small Renal Masses<br />
Fernando Secin, Argentina<br />
Most SRMs Should Be Managed with<br />
Ablation Rather than Surgery<br />
Peter Black, Canada<br />
SRMs Needing Treatment Should Be<br />
Managed with Surgical Resection<br />
Mark Frydenberg, Australia<br />
Session II: Localized Prostate Cancer<br />
Moderator: Nathan Lawrentschuk<br />
Prostate Biomarkers Are Ready for<br />
Prime-Time in Routine Detection of<br />
Prostate Cancer<br />
Scott Eggener, United States<br />
The Utility of Prostate Biomarkers<br />
for Routine Clinical Practice Has<br />
Not Been Established<br />
Badrinath Konety, United States<br />
Debate: Prostate Cancer Prevention<br />
Is Dead<br />
Pro: E. David Crawford, United States<br />
Con: Neil Fleshner, Canada<br />
Session III: Imaging, Biomarkers and<br />
New Therapies<br />
Moderator: Ofer Yossepowitch, Israel<br />
Debate: MRI Can Replace Prostate Biopsy<br />
in Men with Elevated PSA<br />
Pro: TBC<br />
Con: Boris Hadaschik, Germany<br />
Predictors of Prostate Cancer<br />
Specific Mortality after Radical<br />
Prostatectomy<br />
Damien Bolton, Australia<br />
Pelvic LND with RP: Role of<br />
Fluorescence Mapping/<br />
PSMA CT PET<br />
Karim Touijer, United States<br />
New Strategies to Target the<br />
Androgen Receptor<br />
Christopher Evans, United States<br />
Session IV: Controversies in Prostate Cancer<br />
Moderator: Marcelo Bendhack<br />
The New Gleason Grade Scoring System:<br />
Implications for Decision Making<br />
Makarand Khochikar, India<br />
Why Salvage Is Preferable To Adjuvant<br />
Radiation for Men with Positive Margins<br />
Nathan Lawrentschuk<br />
Radical Prostatectomy in Elderly Patients<br />
Derya Tilki, Germany<br />
Cardio-Vascular Complications of ADT<br />
Jehonathan Pinthus, Canada<br />
2nd SIU Nurses’ Educational<br />
Symposium<br />
Chair: Kay Talbot, Australia<br />
The Aging Urology Patient:<br />
Implications for Nursing Practice<br />
Lewis Chan, Australia<br />
Nurse-Led LUTS Clinics<br />
Ja<strong>spr</strong>eet S. Sandhu, United States<br />
Amparo Camacho, United States<br />
Female Incontinence: Plugs, Prongs and<br />
Other Things<br />
Gillian Stearns, United States<br />
Roger Dmochowski, United States<br />
Male Incontinence: Post-Prostatecomy<br />
Incontinence—What Can We Do?<br />
Kay Talbot, Australia<br />
Kurt McCammon, United States<br />
Nursing Solutions in Challenging Cases<br />
Moderator: Kay Talbot, Australia<br />
Panel:<br />
Amparao Camacho, United States<br />
Lana Pepdjonovic, Australia<br />
Mary Schoen, United States<br />
<strong>SIU@U</strong> Studio Session<br />
U Challenge: Residents’ Rapid-Fire Q&A<br />
Karina Sidabutar, Indonesia<br />
Alberto Coscione, United Kingdom<br />
Esther Han, United States<br />
Diego Santillan, Argentina<br />
16<br />
17
www.siu-urology.org
Change language